Dimensional Fund Advisors LP Sells 4,005 Shares of Laboratory Co. of America Holdings (NYSE:LH)

Dimensional Fund Advisors LP cut its position in shares of Laboratory Co. of America Holdings (NYSE:LH - Free Report) by 0.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,363,425 shares of the medical research company's stock after selling 4,005 shares during the period. Dimensional Fund Advisors LP owned 1.63% of Laboratory Co. of America worth $312,656,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Empowered Funds LLC raised its holdings in Laboratory Co. of America by 0.5% during the fourth quarter. Empowered Funds LLC now owns 8,025 shares of the medical research company's stock valued at $1,840,000 after buying an additional 43 shares in the last quarter. SP Asset Management LLC raised its stake in shares of Laboratory Co. of America by 0.3% in the 4th quarter. SP Asset Management LLC now owns 15,186 shares of the medical research company's stock valued at $3,483,000 after acquiring an additional 43 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its holdings in Laboratory Co. of America by 0.4% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 12,780 shares of the medical research company's stock worth $2,931,000 after purchasing an additional 45 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its position in Laboratory Co. of America by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 7,194 shares of the medical research company's stock worth $1,650,000 after purchasing an additional 46 shares during the period. Finally, MassMutual Private Wealth & Trust FSB boosted its position in Laboratory Co. of America by 16.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 354 shares of the medical research company's stock worth $81,000 after purchasing an additional 50 shares during the period. 95.94% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Truist Financial reduced their price objective on shares of Laboratory Co. of America from $285.00 to $274.00 and set a "buy" rating for the company in a research note on Friday, April 11th. Citigroup upgraded shares of Laboratory Co. of America from a "neutral" rating to a "buy" rating and upped their price target for the company from $250.00 to $300.00 in a report on Tuesday, March 4th. UBS Group dropped their price objective on Laboratory Co. of America from $293.00 to $286.00 and set a "buy" rating on the stock in a research note on Tuesday, January 28th. Jefferies Financial Group boosted their price objective on Laboratory Co. of America from $275.00 to $290.00 and gave the stock a "buy" rating in a research report on Thursday, February 6th. Finally, Piper Sandler raised their target price on Laboratory Co. of America from $240.00 to $260.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Four research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $268.77.

Insider Buying and Selling at Laboratory Co. of America

In other Laboratory Co. of America news, CMO Amy B. Summy sold 226 shares of the company's stock in a transaction on Monday, February 24th. The stock was sold at an average price of $250.40, for a total transaction of $56,590.40. Following the transaction, the chief marketing officer now owns 4,544 shares of the company's stock, valued at approximately $1,137,817.60. This represents a 4.74 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Adam H. Schechter sold 6,121 shares of the business's stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $244.62, for a total value of $1,497,319.02. Following the sale, the chief executive officer now owns 86,445 shares of the company's stock, valued at approximately $21,146,175.90. The trade was a 6.61 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 14,258 shares of company stock worth $3,518,177. 0.84% of the stock is currently owned by insiders.

Laboratory Co. of America Price Performance

Shares of NYSE:LH traded up $0.02 during midday trading on Friday, reaching $228.60. 907,300 shares of the company's stock were exchanged, compared to its average volume of 633,498. The firm has a market capitalization of $19.13 billion, a PE ratio of 25.92, a price-to-earnings-growth ratio of 1.71 and a beta of 0.99. The company's 50 day simple moving average is $235.30 and its two-hundred day simple moving average is $235.01. Laboratory Co. of America Holdings has a 12 month low of $191.97 and a 12 month high of $258.59. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.30 and a current ratio of 1.44.

Laboratory Co. of America (NYSE:LH - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The medical research company reported $3.45 earnings per share for the quarter, beating analysts' consensus estimates of $3.40 by $0.05. Laboratory Co. of America had a return on equity of 15.29% and a net margin of 5.73%. Equities research analysts expect that Laboratory Co. of America Holdings will post 16.01 earnings per share for the current fiscal year.

Laboratory Co. of America Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 11th. Investors of record on Thursday, May 29th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 1.26%. Laboratory Co. of America's dividend payout ratio is 32.65%.

Laboratory Co. of America Company Profile

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.